Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Akebia Therapeutics, Inc. (AKBA)  
$1.06 0.01 (0.93%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 144,540,000
Market Cap: 153.21(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8 - $2.24
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 46,856 250,285 277,285 781,354
Total Sell Value $59,038 $383,681 $414,731 $930,953
Total People Sold 2 4 4 5
Total Sell Transactions 2 12 13 28
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 247
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Frieson Ron   –       •      –    2023-06-06 4 A $0.00 $0 D/D 30,000 43,700     -
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2023-05-25 4 S $1.22 $116,760 D/D (95,478) 574,037 8%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2023-05-25 4 S $1.22 $77,270 D/D (63,186) 524,344 8%     
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2023-05-24 4 A $0.00 $0 D/D 200,000 669,515     -
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2023-05-24 4 A $0.00 $0 D/D 200,000 587,530     -
   Spellman David A SVP, CFO and Treasurer   •       –      –    2023-05-16 4 S $1.07 $67,890 D/D (63,567) 446,483 -8%     
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2023-05-16 4 S $1.07 $67,890 D/D (63,567) 530,487 -8%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2023-05-12 4 A $0.00 $0 D/D 100,000 387,530     -
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2023-05-12 4 A $0.00 $0 D/D 200,000 469,515     -
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2023-03-01 4 S $0.88 $12,393 D/D (14,123) 594,054 -26%     
   Butler John P. CEO and President   •       •      –    2023-03-01 4 S $0.88 $80,614 D/D (91,868) 1,568,872 -26%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2023-03-01 4 S $0.88 $11,437 D/D (13,034) 287,530 -26%     
   Spellman David A SVP, CFO and Treasurer   •       –      –    2023-03-01 4 S $0.88 $6,327 D/D (7,210) 510,050 -26%     
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2023-03-01 4 S $0.88 $17,912 D/D (20,412) 269,515 -26%     
   Spellman David A SVP, CFO and Treasurer   •       –      –    2023-02-27 4 S $0.81 $6,131 D/D (7,539) 517,260 -25%     
   Hadas Nicole R. SVP, Chief Legal Officer   •       –      –    2023-02-27 4 S $0.81 $5,430 D/D (6,677) 300,564 -25%     
   Butler John P. CEO and President   •       •      –    2023-02-27 4 S $0.81 $31,416 D/D (38,632) 1,660,740 -25%     
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2023-02-27 4 S $0.81 $6,131 D/D (7,539) 608,177 -25%     
   Dahan Michel SVP, Chief Operating Officer   •       –      –    2023-02-27 4 S $0.81 $8,205 D/D (10,090) 289,927 -25%     
   Spellman David A SVP, CFO and Treasurer   •       –      –    2023-01-31 4 A $0.00 $0 D/D 196,200 524,799     -
   Butler John P. CEO and President   •       •      –    2023-01-31 4 A $0.00 $0 D/D 293,125 1,699,372     -
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2023-01-31 4 A $0.00 $0 D/D 196,200 615,716     -
   Burke Steven Keith SVP, Chief Medical Officer   •       –      –    2022-08-31 4 S $0.36 $416 D/D (1,147) 418,016 -89%     
   Spellman David A SVP, CFO and Treasurer   •       –      –    2022-06-08 4 A $0.00 $0 D/D 200,000 328,599     -
   Gilman Steven C   –       •      –    2022-06-03 4 AS $0.36 $1,653 D/D (4,567) 43,430 -30%     
  247 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us